Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. FDA
Biotech
FDA chides Applied Therapeutics' trial conduct in warning letter
While Applied Therapeutics plans to appeal a recent rejection of govorestat, issues with the biotech’s clinical conduct could hamper those plans.
Fraiser Kansteiner
Dec 4, 2024 11:21am
Lykos' MDMA treatment for PTSD has been quashed at the FDA
Aug 10, 2024 9:07am
FDA's Richard Pazdur explains confirmatory trial rejection, more
Apr 8, 2024 6:00am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm
'The Top Line': Unraveling Alzheimer's disease treatments
Oct 13, 2023 6:00am
Panel of FDA experts endorses Pfizer's RSV vaccine prospect
Feb 28, 2023 4:59pm
